A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters.
Acta Pharmacol Sin
; 40(7): 895-907, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-30573812
Full text:
1
Database:
MEDLINE
Main subject:
Sulfonamides
/
Benzamides
/
Organic Anion Transporters, Sodium-Dependent
/
Symporters
/
Non-alcoholic Fatty Liver Disease
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2019
Type:
Article
Affiliation country:
China